NCT00429494View on ClinicalTrials.gov

GnRH Analogue for Ovarian Function Preservation in Hematopoietic Stem Cell Transplantation Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 30, 2002

Primary Completion Date

June 30, 2011

Study Completion Date

June 30, 2011

Conditions
AmenorrheaPremature Ovarian FailureOvarian Function Insufficiency
Interventions
DRUG

Leuprolide Acetate

22.5 mg IM injection 2 months before transplant and 3 months post-transplant.

BEHAVIORAL

Questionnaire

Questionnaires taking about 15 minutes to complete.

PROCEDURE

Hematopoietic Stem Cell Transplantation

Stem cell infusion on Day 0.

Trial Locations (1)

77030

UT MD Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

TAP Pharmaceutical Products Inc.

INDUSTRY

lead

M.D. Anderson Cancer Center

OTHER

NCT00429494 - GnRH Analogue for Ovarian Function Preservation in Hematopoietic Stem Cell Transplantation Patients | Biotech Hunter | Biotech Hunter